Improving Adherence to Pharmacological Treatment

NACompletedINTERVENTIONAL
Enrollment

689

Participants

Timeline

Start Date

September 30, 2000

Primary Completion Date

May 31, 2005

Study Completion Date

May 31, 2005

Conditions
Medication Adherence
Interventions
BEHAVIORAL

systems-based and pharmacist-mediated program

Patients in the SI were seen by a study pharmacists prior to discharge to establish a relationship with the patient, explain the pharmacist's role in the study, provide education about all discharge medications and a medication card listing all medications and their manner of use, and set the framework for the follow-up telephone calls. Patients received pharmacist-delivered adherence counseling telephone contacts that took place at two weeks following discharge, and at months 1, 3, 6, and 9 oriented towards assisting patients to remain adherent to prescribed lipid-lowering and other medications, and also towards ensuring that all patients were either documented to be at the LDL-C goal, or were assisted to reach the goal by facilitating the scheduling of repeat lipid measurement as needed and providing information, guidelines and prompts to the patient's physician or nurse practitioner.

Trial Locations (1)

01655

UMass Memorial Medical Center, Worcester

All Listed Sponsors
collaborator

National Institutes of Health (NIH)

NIH

lead

University of Massachusetts, Worcester

OTHER

NCT00848224 - Improving Adherence to Pharmacological Treatment | Biotech Hunter | Biotech Hunter